StockSignal
  • Screen for fundamentally interesting stocks
Sign in
Butterfly Network Inc. logo

Butterfly Network Inc.

BFLY · ARCX · Medical Devices · United States

Market Capitalization1.01B USD
Trailing P/E-12.69 USD
52-Week Change32.91 USD
Beta2.33 USD

Butterfly Network Inc. is a digital health company specializing in portable, semiconductor-based ultrasound technology. It develops and commercializes whole-body handheld ultrasound probes, including the Butterfly iQ+, iQ3, iQ+ Bladder for specialized bladder scanning, and iQ+ Vet for veterinary applications, all powered by patented Ultrasound-on-Chip™ technology. These single-probe devices enable real-time imaging across multiple specialties and integrate with cloud-based software, advanced AI tools like Compass AI™ for workflow management, ambient documentation, and quality assurance, as well as enterprise platforms for hospital networks. The solutions support point-of-care ultrasound (POCUS) in diverse settings, from individual practices and health systems to medical education and global health initiatives in limited-resource areas. Butterfly Network Inc. serves clinicians, healthcare providers, veterinarians, and organizations worldwide, enhancing clinical decision-making, improving efficiencies, and promoting accessible medical imaging. Founded in 2011 and headquartered in Burlington, Massachusetts, the company drives innovation in democratizing ultrasound for better patient outcomes.

Industry

Medical Devices

Healthcare sector · United States

Stories

Structural patterns identified in Butterfly Network Inc.

No stories identified yet.

Key Metrics

Market Capitalization
1.01BUSD
NormalMar 20, 2026
Trailing P/E
-12.69USD
ExtremeMar 20, 2026
Revenue (TTM)
97.61MUSD
NormalMar 20, 2026
Profit Margin
-78.95%
BelowNormalMar 20, 2026
Beta
2.33USD
NormalMar 20, 2026
52-Week Change
32.91USD
ExtremeMar 20, 2026

This company does not currently pay dividends.

Valuation9
Market Capitalization
1.01BUSD
NormalMar 20, 2026
Enterprise Value
957.19MUSD
NormalMar 20, 2026
Trailing P/E
-12.69USD
ExtremeMar 20, 2026
Forward P/E
-42.70USD
ExtremeMar 20, 2026
PEG Ratio
-42.70USD
ExtremeMar 20, 2026
Price to Sales (TTM)
11.14USD
NormalMar 20, 2026
Price to Book (MRQ)
5.53USD
NormalMar 20, 2026
Enterprise to Revenue
9.81USD
NormalMar 20, 2026
Enterprise to EBITDA
-17.67USD
ExtremeMar 20, 2026
Profitability & Growth17
Gross Margin
67.34%
NormalMar 20, 2026
Profit Margin
-78.95%
BelowNormalMar 20, 2026
Operating Margin
-36.13%
BelowNormalMar 20, 2026
Return on Assets (TTM)
-0.1317USD
NormalMar 20, 2026
Return on Equity (TTM)
-0.4225USD
NormalMar 20, 2026
Revenue (TTM)
97.61MUSD
NormalMar 20, 2026
Revenue per Share (TTM)
0.3950USD
NormalMar 20, 2026
Quarterly Revenue Growth
0.4100USD
NormalMar 20, 2026
Gross Profit (TTM)
63.13MUSD
NormalMar 20, 2026
EBITDA
-54.16MUSD
ExtremeMar 20, 2026
Net Income (TTM)
-77.06MUSD
NormalMar 20, 2026
Quarterly Earnings Growth (YoY)
0.4100USD
NormalMar 20, 2026
Operating Cash Flow (TTM)
-12.70MUSD
NormalMar 20, 2026
Levered Free Cash Flow (TTM)
12.72MUSD
NormalMar 20, 2026
Trailing Annual Dividend Rate
0.00USD
NormalMar 20, 2026
Trailing Annual Dividend Yield
0.00%
NormalMar 20, 2026
Payout Ratio
0.00USD
NormalMar 20, 2026
Financial Strength31
Shares Outstanding
253.75MShares
NormalMar 20, 2026
Float Shares
185.22MUSD
NormalMar 20, 2026
Shares Short
29.60MShares
NormalMar 20, 2026
Short Ratio
3.95USD
NormalMar 20, 2026
Short % of Shares Outstanding
0.1529USD
NormalMar 20, 2026
% Held by Insiders
0.1302USD
NormalMar 20, 2026
% Held by Institutions
0.4853USD
NormalMar 20, 2026
Total Cash (MRQ)
150.49MUSD
NormalMar 20, 2026
Total Cash per Share (MRQ)
0.5910USD
NormalMar 20, 2026
Total Debt (MRQ)
20.40MUSD
NormalMar 20, 2026
Total Debt to Equity (MRQ)
10.41USD
AboveNormalMar 20, 2026
Current Ratio (MRQ)
3.83USD
AboveNormalMar 20, 2026
Book Value per Share (MRQ)
0.7720USD
NormalMar 20, 2026
Total Assets
296.53M
NormalFY2025 · Dec 31, 2025
Total Current Assets
249.10M
NormalFY2025 · Dec 31, 2025
Total Liabilities
100.55M
NormalFY2025 · Dec 31, 2025
Total Non-current Assets
47.43M
NormalFY2025 · Dec 31, 2025
Total Non-current Liabilities
35.44M
NormalFY2025 · Dec 31, 2025
Total Current Liabilities
65.12M
NormalFY2025 · Dec 31, 2025
Cash & Cash Equivalents
150.49M
NormalFY2025 · Dec 31, 2025
Accounts Receivable
26.74M
NormalFY2025 · Dec 31, 2025
Inventory
61.39M
NormalFY2025 · Dec 31, 2025
Accounts Payable
5.44M
NormalFY2025 · Dec 31, 2025
Short-term Debt
2.68M
NormalFY2025 · Dec 31, 2025
Deferred Revenue
26.91M
NormalFY2025 · Dec 31, 2025
Other Current Liabilities
9.71M
NormalFY2025 · Dec 31, 2025
Long-term Debt
17.72M
NormalFY2025 · Dec 31, 2025
Other Non-current Liabilities
8.32M
NormalFY2025 · Dec 31, 2025
Common Stock (Book)
26.00K
NormalFY2025 · Dec 31, 2025
Retained Earnings
-879.19M
NormalFY2025 · Dec 31, 2025
Total Shareholders' Equity
195.98M
NormalFY2025 · Dec 31, 2025
Market & Technical9
52-Week Low
1.32USD
NormalMar 20, 2026
52-Week High
5.03USD
NormalMar 20, 2026
52-Week Change
32.91USD
ExtremeMar 20, 2026
Beta
2.33USD
NormalMar 20, 2026
50-Day MA
3.83USD
NormalMar 20, 2026
200-Day MA
2.63USD
NormalMar 20, 2026
Avg 10-Day Volume
4.56MUSD
NormalMar 20, 2026
Avg 30-Day Volume
6.91MUSD
NormalMar 20, 2026
Diluted EPS (TTM)
-0.3100USD
NormalMar 20, 2026

Coordination

Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination

Supply Chain

Medical Devices Supply Chain

The medical devices supply chain is shaped by three structural constraints that most manufacturing industries do not face: a regulatory classification cascade where risk level determines the years of validation required before a product can be sold, sterilization and biocompatibility requirements that restrict which materials and processes are permitted, and installed base dependency where hospitals commit to ecosystems that cannot be switched without replacing training, consumables, and data infrastructure.

StockSignal
  • Blog
  • Industries
  • Glossary
  • Stories
  • Coordinations
  • Constraint Archetypes
  • Legal

Contact

© 2026 StockSignal. All rights reserved.